Cita APA (7a ed.)

Luo, S., Wu, S., Chen, W., Wu, C., Chiu, T., Yang, Y., . . . Chen, C. (2021). Low-dose aspirin confers a survival benefit in patients with pathological advanced-stage oral squamous cell carcinoma. Nature Portfolio.

Cita Chicago Style (17a ed.)

Luo, Sheng-Dean, et al. Low-dose Aspirin Confers a Survival Benefit in Patients with Pathological Advanced-stage Oral Squamous Cell Carcinoma. Nature Portfolio, 2021.

Cita MLA (8a ed.)

Luo, Sheng-Dean, et al. Low-dose Aspirin Confers a Survival Benefit in Patients with Pathological Advanced-stage Oral Squamous Cell Carcinoma. Nature Portfolio, 2021.